These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 8772220)

  • 1. Changes in haemostatic factors and activation products after exercise in healthy subjects with different ages.
    van den Burg PJ; Hospers JE; van Vliet M; Mosterd WL; Bouma BN; Huisveld IA
    Thromb Haemost; 1995 Dec; 74(6):1457-64. PubMed ID: 8772220
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Coagulation and fibrinolysis are in balance after moderate exercise in middle-aged participants.
    Menzel K; Hilberg T
    Clin Appl Thromb Hemost; 2009; 15(3):348-55. PubMed ID: 19022797
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blood coagulation, fibrinolytic activity and lipid profile in subclinical thyroid disease: subclinical hyperthyroidism increases plasma factor X activity.
    Erem C
    Clin Endocrinol (Oxf); 2006 Mar; 64(3):323-9. PubMed ID: 16487444
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dyslipidemias and fibrinolysis.
    Puccetti L; Bruni F; Pasqui AL; Pastorelli M; Bova G; Cercignani M; Palazzuoli A; Auteri A
    Ital Heart J; 2002 Oct; 3(10):579-86. PubMed ID: 12478815
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A randomised, controlled study of the effects of aerobic exercise and dietary fish on coagulation and fibrinolytic factors in type 2 diabetics.
    Dunstan DW; Mori TA; Puddey IB; Beilin LJ; Burke V; Morton AR; Stanton KG
    Thromb Haemost; 1999 Mar; 81(3):367-72. PubMed ID: 10102462
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Haemostatic and inflammatory biomarkers in advanced chronic heart failure: role of oral anticoagulants and successful heart transplantation.
    Cugno M; Mari D; Meroni PL; Gronda E; Vicari F; Frigerio M; Coppola R; Bottasso B; Borghi MO; Gregorini L
    Br J Haematol; 2004 Jul; 126(1):85-92. PubMed ID: 15198737
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term treatment with growth hormone decreases plasminogen activator inhibitor-1 and tissue plasminogen activator in growth hormone-deficient adults.
    Johansson JO; Landin K; Johannsson G; Tengborn L; Bengtsson BA
    Thromb Haemost; 1996 Sep; 76(3):422-8. PubMed ID: 8883281
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Balanced activation of coagulation and fibrinolysis after a 2-h triathlon.
    Bärtsch P; Welsch B; Albert M; Friedmann B; Levi M; Kruithof EK
    Med Sci Sports Exerc; 1995 Nov; 27(11):1465-70. PubMed ID: 8587481
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of highly purified urinary FSH and recombinant FSH on haemostasis: an open-label, randomized, controlled trial.
    Ricci G; Cerneca F; Simeone R; Pozzobon C; Guarnieri S; Sartore A; Pregazzi R; Guaschino S
    Hum Reprod; 2004 Apr; 19(4):838-48. PubMed ID: 15016779
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro clot lysis as a potential indicator of thrombus resistance to fibrinolysis--study in healthy subjects and correlation with blood fibrinolytic parameters.
    Colucci M; Scopece S; Gelato AV; Dimonte D; Semeraro N
    Thromb Haemost; 1997 Apr; 77(4):725-9. PubMed ID: 9134650
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of simvastatin on hemostatic and fibrinolytic regulators in Type 2 diabetes mellitus.
    Ludwig S; Dharmalingam S; Erickson-Nesmith S; Ren S; Zhu F; Ma GM; Zhao R; Fenton JW; Ofosu FA; Velthuis HT; van Mierlo G; Shen GX
    Diabetes Res Clin Pract; 2005 Nov; 70(2):110-8. PubMed ID: 16188573
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of coagulation and fibrinolytic systems in patients with CLI is not normalized after surgical revascularisation.
    Pärsson H; Holmberg A; Siegbahn A; Bergqvist D
    Eur J Vasc Endovasc Surg; 2004 Feb; 27(2):186-92. PubMed ID: 14718902
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blood coagulation, fibrinolysis and lipid profile in patients with primary hyperparathyroidism: increased plasma factor VII and X activities and D-Dimer levels.
    Erem C; Kocak M; Hacihasanoglu A; Yilmaz M; Saglam F; Ersoz HO
    Exp Clin Endocrinol Diabetes; 2008 Nov; 116(10):619-24. PubMed ID: 18484067
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The coagulation and fibrinolytic responses of baboons after in vivo thrombin generation--effect of interleukin 6.
    Kruithof EK; Mestries JC; Gascon MP; Ythier A
    Thromb Haemost; 1997 May; 77(5):905-10. PubMed ID: 9184401
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human gender differences in fibrinolytic responses to exercise training and their determinants.
    Kulaputana O; Macko RF; Ghiu I; Phares DA; Goldberg AP; Hagberg JM
    Exp Physiol; 2005 Nov; 90(6):881-7. PubMed ID: 16118237
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased fibrinolytic activity during use of oral contraceptives is counteracted by an enhanced factor XI-independent down regulation of fibrinolysis: a randomized cross-over study of two low-dose oral contraceptives.
    Meijers JC; Middeldorp S; Tekelenburg W; van den Ende AE; Tans G; Prins MH; Rosing J; Büller HR; Bouma BN
    Thromb Haemost; 2000 Jul; 84(1):9-14. PubMed ID: 10928462
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of coagulation and fibrinolysis in childhood diarrhoea-associated haemolytic uraemic syndrome.
    Nevard CH; Jurd KM; Lane DA; Philippou H; Haycock GB; Hunt BJ
    Thromb Haemost; 1997 Dec; 78(6):1450-5. PubMed ID: 9423793
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relation of habitual diet and cardiorespiratory fitness to blood coagulation and fibrinolytic factors.
    Rankinen T; Rauramaa R; Väisänen S; Penttilä IM; Uusitupa M
    Thromb Haemost; 1994 Feb; 71(2):180-3. PubMed ID: 8191395
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A longitudinal study of the relationships between haemostatic, lipid, and oestradiol changes during normal human pregnancy.
    Sattar N; Greer IA; Rumley A; Stewart G; Shepherd J; Packard CJ; Lowe GD
    Thromb Haemost; 1999 Jan; 81(1):71-5. PubMed ID: 9974378
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasminogen activators (t-PA and u-PA) and plasminogen activators inhibitors (PAI-1 and PAI-2) in some myeloproliferative syndromes.
    Rość D; Kremplewska-Nalezyta E; Gadomska G; Zastawna E; Michalski A; Drewniak W
    Med Sci Monit; 2000; 6(4):684-91. PubMed ID: 11208392
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.